FR2147277A1 - - Google Patents

Info

Publication number
FR2147277A1
FR2147277A1 FR7227161A FR7227161A FR2147277A1 FR 2147277 A1 FR2147277 A1 FR 2147277A1 FR 7227161 A FR7227161 A FR 7227161A FR 7227161 A FR7227161 A FR 7227161A FR 2147277 A1 FR2147277 A1 FR 2147277A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7227161A
Other languages
French (fr)
Other versions
FR2147277B1 (xx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra USA Inc
Original Assignee
Astra Pharmaceutical Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceutical Products Inc filed Critical Astra Pharmaceutical Products Inc
Publication of FR2147277A1 publication Critical patent/FR2147277A1/fr
Application granted granted Critical
Publication of FR2147277B1 publication Critical patent/FR2147277B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7227161A 1971-07-28 1972-07-27 Expired FR2147277B1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16703171A 1971-07-28 1971-07-28

Publications (2)

Publication Number Publication Date
FR2147277A1 true FR2147277A1 (xx) 1973-03-09
FR2147277B1 FR2147277B1 (xx) 1976-04-16

Family

ID=22605664

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7227161A Expired FR2147277B1 (xx) 1971-07-28 1972-07-27

Country Status (23)

Country Link
JP (1) JPS565220B1 (xx)
AR (1) AR193748A1 (xx)
AT (1) AT317185B (xx)
AU (1) AU476000B2 (xx)
BE (1) BE786875A (xx)
BR (1) BR7205069D0 (xx)
CA (1) CA982148A (xx)
CH (1) CH574397A5 (xx)
CS (1) CS171171B2 (xx)
DD (1) DD101389A5 (xx)
DK (1) DK142843B (xx)
ES (1) ES404739A1 (xx)
FI (1) FI55492C (xx)
FR (1) FR2147277B1 (xx)
GB (1) GB1374367A (xx)
HU (1) HU163818B (xx)
IE (1) IE36607B1 (xx)
NL (1) NL176254C (xx)
NO (1) NO137500C (xx)
PL (1) PL84891B1 (xx)
SE (1) SE399702B (xx)
SU (1) SU441704A3 (xx)
ZA (1) ZA724512B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0472325A2 (en) * 1990-08-08 1992-02-26 Kissei Pharmaceutical Co., Ltd. Acid addition salts of an optically active alaninanilide compound and pharmaceutical compositions containing the same

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57182525U (xx) * 1981-05-15 1982-11-19
JPH01128053U (xx) * 1988-02-24 1989-08-31
GB2267709A (en) * 1992-06-11 1993-12-15 Merck & Co Inc Novel process for the preparation of alpha-aminoacylanilides
CA3027255C (en) 2009-07-10 2022-06-21 The General Hospital Corporation Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
DE102012210082A1 (de) * 2012-06-15 2013-12-19 Hilti Aktiengesellschaft Werkzeugmaschine und Steuerungsverfahren
JP6833811B2 (ja) 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
AU2020237474A1 (en) 2019-03-11 2021-09-30 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20220123381A (ko) 2019-11-06 2022-09-06 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
EP4118070A4 (en) 2020-03-11 2024-04-10 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0472325A2 (en) * 1990-08-08 1992-02-26 Kissei Pharmaceutical Co., Ltd. Acid addition salts of an optically active alaninanilide compound and pharmaceutical compositions containing the same
EP0472325A3 (en) * 1990-08-08 1992-03-04 Kissei Pharmaceutical Co., Ltd. Acid addition salts of an optically active alaninanilide compound and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
NL176254B (nl) 1984-10-16
NL7210418A (xx) 1973-01-30
CA982148A (en) 1976-01-20
NO137500B (no) 1977-11-28
GB1374367A (en) 1974-11-20
IE36607L (en) 1973-01-28
DK142843B (da) 1981-02-09
SE399702B (sv) 1978-02-27
FR2147277B1 (xx) 1976-04-16
JPS565220B1 (xx) 1981-02-04
DK142843C (xx) 1981-08-31
AU4488672A (en) 1974-01-31
IE36607B1 (en) 1976-12-08
DE2235745B2 (de) 1976-08-19
AR193748A1 (es) 1973-05-22
PL84891B1 (en) 1976-04-30
ZA724512B (en) 1973-08-29
AU476000B2 (en) 1976-09-09
NO137500C (no) 1978-03-08
AT317185B (de) 1974-08-12
ES404739A1 (es) 1975-07-16
FI55492B (fi) 1979-04-30
SU441704A3 (ru) 1974-08-30
FI55492C (fi) 1979-08-10
CH574397A5 (xx) 1976-04-15
DD101389A5 (xx) 1973-11-05
DE2235745A1 (de) 1973-02-22
CS171171B2 (xx) 1976-10-29
BR7205069D0 (pt) 1973-07-17
HU163818B (xx) 1973-11-28
NL176254C (nl) 1985-03-18
BE786875A (fr) 1973-01-29

Similar Documents

Publication Publication Date Title
FR2147277B1 (xx)
AU2658571A (xx)
AU2691671A (xx)
AU2564071A (xx)
AU2485671A (xx)
AU3005371A (xx)
AU2684071A (xx)
AU2742671A (xx)
AU2836771A (xx)
AU2399971A (xx)
AU2724971A (xx)
AU3025871A (xx)
AU2503871A (xx)
AU2456871A (xx)
AU2455871A (xx)
AU2486471A (xx)
AU2669471A (xx)
AU2706571A (xx)
AU2415871A (xx)
AU2654071A (xx)
AU3038671A (xx)
AU2473671A (xx)
AU2588771A (xx)
AU2726271A (xx)
AU2577671A (xx)

Legal Events

Date Code Title Description
TP Transmission of property